Clinical Trial Update: The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether doubling the dose of oral esomeprazole reduces rebleeding in patients with bleeding peptic ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Bleeding
• Peptic Ulcer Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Peptic Ulcer Bleeding | Phase 4 | Status: COMPLETED